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1 Microfiltration in Biopharmaceutical
Process Design
1.1 Typical Aspects of Biopharmaceutical
Processing
Biopharmaceuticals (proteins and derivatives, parts of DNA
and hormones [1]) are usually produced by cell culture pro-
cesses. The manufacturing process of therapeutic proteins
can be separated in an upstream part, comprising the cell
culture process and the harvest, and in a downstream part,
the purification of the target protein and formulation of a
protein drug [2]. The manufacturing process is concluded
by fill & finish, the final sterile filtration and the filling of a
protein drug [3]. An overview of the bioprocess is shown in
Fig. 1.
Every biopharmaceutical process contains various filtra-
tion steps [7]. Product media, buffer and cell culture media
have to be sterile filtered [8, 9]. Main filtration steps are
depth filtration, bioburden reduction and sterile filtration,
virus filtration, ultra- and diafiltration [5, 10, 11].
There is a general trend towards single-use equipment
in biopharmaceutical production. Consequently, filtration
equipment is single use as well, using filter capsules, which
can be easily handled and do not need cleaning in contrast
to a multi-use filter housing [12]. A review on the subject of
membrane modules for process scale is published by van
Reis [9]. An example for single-use devices are T-Style
MaxiCaps by Sartorius Stedim Biotech, which were used
in this study and are described in Sect. 2.2.1. Filtration
equipment contains usually 10’’–30’’ capsules depending on
the batch size. Filter capsules are often used as a component
of a ready to use preconfigured system. Only the tubing has
to be connected before use. Capsules contain pleated single
or double-layer membranes, encompassed by non-wovens,
with filtration areas usually between 0.6 and 1.1 m2, for 10’’
[9, 13, 14].
Biopharmaceutical media are chemically seen suspen-
sions or colloidal solutions. Product and central component
of formulation are proteins, which are dispersed nanoparti-
cles in aqueous solution. Further formulation components
are dissolved molecules like buffer, electrolytes, sugar, sur-
factants, etc. [15, 16]. Viscosity can vary between 1 cP for
diluted systems and 50 cP for full therapeutic formulations
in final fill filtration. The viscosity of the formulation has
impact on the filtration flow across the filter. High-concen-
trated protein solutions are fluids with non-Newtonian
behavior and show shear thinning behavior [17]. Composi-
tion, pH and viscosity of product formulation change in
course of the biopharmaceutical process, resulting in a dif-
ferent degree of filter fouling [18, 19]. Filter fouling is usu-
ally not an issue for diluted solutions but a severe problem
for clarification filtration, filtration of bulk drug substance
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and final fill filtration, depending on concentration of solu-
tion, particle load and process conditions [7, 20, 21].
Most biopharmaceutical filtration steps are constant flow
driven [22, 23]. This mode of operation fits perfectly in the
general biopharmaceutical process flow [7]. Filter fouling is
usually lower for constant flow operation [24].
Main process parameters for filter devices are flow rate
and transmembrane pressure. Their relationship during fil-
tration of a fluid through a membrane filter can be described
by the Darcy equation (see Eq. (6), Sect. 2.1) independent of
the mode of operation.
For biopharmaceutical process design, the overall process
has to be considered, not just an isolated filtration step. A
filtration process is always part of a sequential arrangement,
which determines the necessary process parameters. Flow
rates for example have to be high enough to keep up with
filling machines [25], to provide buffer for column chroma-
tography, or to evade enzymatic degradation [26]. Further-
more, it is well known that process conditions have impact
on filter fouling or product quality. A high flow rate can
cause protein aggregation due to shear stress [18]. A very
low flow rate can increase filter fouling due to a long inter-
action time between protein and membrane surface [18].
Biopharmaceutical process engineering shall ensure max-
imum product yield and process consistency by choice of
operation conditions and equipment. The food and drug
administration (FDA) has strengthened regulatory meas-
ures to improve biopharmaceutical process consistency. Fil-
tration steps play an important role for the proper removal
of microorganisms and particular contaminants, and by this
have an essential impact on the smooth progress of the
whole biopharmaceutical process, the product yield and
quality [7, 8, 27]. Since the biopharmaceutical formulations
are quite expensive, filtration equipment should be properly
sized to avoid dead volume.
1.2 Current Upscaling Procedure for Dead-End
Microfiltration
Scale-up is an engineering approach in process filtration for
selection of suitable process filtration equipment, filter siz-
ing, and process parameters, i.e., the estimation of the nec-
essary filter area or the filter capacity for filtration of a given
fluid volume for a specified set of operating conditions.
Experimentally, the filter capacity for filtration of a given
fluid phase is determined by small-scale filtration trials with
the area Atest, usually on the basis of constant pressure fil-
tration trials [28]. For these small-scale experiments, scaling
devices with a minimal membrane area are available, such
as Sartoscale 25 by Sartorius Stedim Biotech GmbH [29],
Optiscales by Merck KGaA [28] or the Mini Kleenpak
products by Pall Corporation [30].
In small scale, direct measurement of flow rate is often
not possible with the necessary accuracy. Alternatively, the
filtered mass can be collected by a balance and the flow rate
can be calculated by the first derivative of the volume with
respect to time. Currently, discussion of filtration processes
and filter fouling are quite frequently based on the filtered
volume versus time plot.
In literature, scale-up experiments are performed by
determination of the filter capacity. The filter capacity is
defined by the Vfinal value, which is the maximum reached
filtrate volume required for complete filter blocking. In a
lab-scale trial pressure, filtrate volume and time are re-
corded. Resulting experimental data are displayed in a vol-
ume vs. time plot.
The necessary membrane area Abatch for filtration of a
batch size of the volume Vbatch can be calculated by the fol-





Usually the risk of underestimating the filter area is mini-
mized by introducing a safety factor, SF. The safety factor is
necessary to compensate the variability usually connected
with upscaling processes; e.g., industrial membranes show a
variability of performance and filtration devices might vary
concerning geometric dimensions. This may be the case for
very small scaling devices with filter area of few square cen-
timeters. Additionally, there is a big range of possible pro-
cess conditions for filtration [21, 31]. Safety factors are giv-
en with values of 0.75–0.9 [32], 1.1–2.5 [33], 1.3–2 [34], 1.5
[9] or 2 [24], in dependence of the process (constant flow
or constant pressure) [32, 35] or of the blocking mechanism
of the filtration [32]. The importance of safety factors for
biopharmaceutical process development is reported by Lutz
et al. [33].
Customers in the biopharmaceutical industry usually
require upscaling trials with a minimum amount of the for-
mulation, as the respective formulations are quite expensive
and thermodynamically not stable. Therefore, small-scale
trials must be reliable, because they are used to evaluate the
impact on product quality and the basics for the large-scale
filtration process. To minimize the amount of necessary
scaling experiments, first the basic aspects of a filtration
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process have to be evaluated (batch volume, process time,
necessary filtration flow). Mathematic modeling of the fil-
tration process helps to minimize experimental efforts, and
with that to reduce volume of filtration media required for
test trials.
For upscaling it has to be considered that biopharmaceut-
ical formulations usually show process-dependent filter
fouling. Therefore, the small-scale trials should be per-
formed in the same mode as the process trials, usually with
a constant flow rate.
The filter capacity Vfinal can be extrapolated by fitting a
pore blocking model to the experimental filtration data
[36]. Modeling of filter fouling on the basis of pore blocking
models has a history in filtration technology that began in
the 1930s. Usually four blocking models are used for
description of filter fouling: complete blocking, standard
blocking, intermediate blocking, and cake filtration. The







The blocking index n varies with values between 0 and 2
in dependence on the fouling mechanism. Theoretical back-
ground and calculation basis are described in a review
article by Iritani et al. [36]. The blocking models were devel-
oped for ideal fluids with a narrow particle size distribution
flowing through ideal membranes with cylindrical pores.
Neither membranes nor fluids fulfill these model require-
ments in industrial process filtration. Microfilter mem-
branes exhibit a sponge-like porous structure rather than
cylindrical pores [9, 36]. Most industrial process media,
especially biopharmaceutical formulations, are colloidal
solutions with limited thermodynamic stability as described
above [15, 16, 37]. Dispersed particles are not necessarily
spherical and undergo interactions between each other and
with the membrane surface. Moreover, the blocking mecha-
nism can change during filtration, e.g. at the beginning
small particles deposit within the membrane pores until the
pores are so tight, they get plugged by a particle. Therefore,
the predictability of the use of single blocking models for
upscaling and filter sizing is limited and upscaling results
based on those models deviate significantly [32, 35, 38]. The
predictability can be slightly improved by combining several
blocking models. The combination of blocking models
extends the number of parameters that can be modified,
resulting in generated data closer to experimental measure-
ments [39, 40].
An example of the mentioned approach for upscaling of
filtration processes, set of experiments and working meth-
ods behind is given by Rajniak et al. [32] for the redundant
sterilizing filtration of an active pharmaceutical ingredient
solution using a PVDF membrane filter with scaling from a
47-mm filter disc to pilot and production scale. Different
blocking models and combinations were applied for curve
fitting. The calculated values usually underestimated the
experimentally determined capacity values and were conse-
quently regarded as worst-case scenario. An extra safety fac-
tor of 2 was included due to large batch-to-batch variation.
Furthermore, the article gives an overview about resistances
of filtration equipment in dependence on scale and details
of construction. Finally, it was stated that sterilizing filtra-
tion is not a linearly scalable unit operation due to the fact
that the pressure-normalized initial flux is different for the
scaling devices used. The initial flux decreases with increas-
ing filter area due to occurrence of additional flow resistan-
ces connected with device construction, tubing and fittings
[32]. Other reviews about experimental procedure, theoreti-
cal approaches, and aspects to consider for conducting
microfiltration upscaling studies are given in the literature
[31, 32, 34, 41].
To improve the predictability and to avoid the use of
blocking laws, it is generally recommended to do calcula-
tions based on small-scale filtration trials run until nearly
complete membrane blocking. In case of limited amount of
test solution this is a problem.
There is a strong trend in recent literature to use flow rate
and resistance to monitor filtration processes and filter foul-
ing [36]. The resistance can be calculated by the Darcy
equation (Sect. 2.1). The viscosity of a filtration fluid is the
only value required for the calculation of the membrane
resistance on top of the parameter set encompassing the fil-
tration time, flux (or volume) and differential pressure. The
approach has many advantages: Monitoring of flow rate
and resistance vs. throughput (filtrate volume per effective
membrane area) connects both change of flow rate and the
occurrence of fouling processes with the passage of contam-
inants through the filter. Moreover, it gives insight in the
process dependency of filter fouling, which is quite strong
for biopharmaceutical process filtration. The change of the
initial water flux with device size can be visualized. The
magnitude of the resistance of the membrane and the filter
housing can be quantified, which allows to identify experi-
mental issues, e.g., reduction of effective filter area by insuf-
ficient wetting or inclusion of air within a system.
1.3 Aim of this Work
This work presents a flow rate and resistance-in-series
based model for upscaling of filtration processes, which
does not require knowledge of blocking mechanism. In the
following the approach for this model is described begin-
ning with the chapter model development, which contains
the necessary theoretical background for the description of
flow rate and resistance (Sect. 2.1), information about the
experimental setups and filter devices (Sect. 2.2), and their
flow properties (Sect. 2.3). Sect. 2.4 explains how filter devi-
ces can be described by a resistance-in-series model, based
on the Darcy-equation, and how the device resistance and
effective filter area can be determined by water flow mea-
surements.





Filtration trials are performed and described in Sect. 2.5
in order to show how the formation of the fouling layer
can be visualized by calculation of the filtration flux or
the resistance versus throughput curves. Basic equations for
modeling of filtration curves for target filtration conditions
and devices on the basis of small-scale filtration trials are
summarized in Sect. 2.6 for constant pressure filtration
processes and in Sect. 2.7 for constant flow filtration pro-
cesses.
Finally, case studies are described to validate the scale-up
approach and the calculation basis. Data are summarized in
the chapter model validation with a constant pressure filtra-
tion upscaling example (Sect. 3.1) and a constant flow
downscaling example (Sect. 3.2).
2 Model Development
2.1 Flow Rate and Resistance in Microfiltration –
General Aspects
For evaluation of filtration experiments, volume V, differen-
tial pressure DP and the corresponding time t are moni-
tored. The volume V, normed by the effective filtration area









The filtration flux J can be defined as the normed water




The flow rate of a fluid through a porous membrane filter
can be described with the Darcy equation, which is usually




The flow rate J depends on the filtration process param-
eter Dp, the fluid viscosity h, and the membrane properties
(resistance R and membrane area Amem).
Darcy’s law is an empirical equation, which was later
explained as a simplified solution of the Navier-Stokes
equation. The Darcy equation is valid for laminar flow,
hence, can be applied in case of low Reynolds numbers
[42]. The Reynolds number Re is the ratio of inertia forces
to the viscous forces. Within a straight tube Re is a function
of filtration flux J, density r, the inner tube diameter di,





Knowing the Reynolds number is important for the esti-
mation of flow properties, whether fluid flow is laminar or
turbulent. The critical Reynolds number in a straight tube is
Re = 2320. Below that value, fluid flow is laminar. Between
2320 < Re < 8000 both laminar and turbulent fluid flow can
occur, above Re = 8000 fluid flow is turbulent [43]. A turbu-
lent flow rate causes additional resistances in the system.
Hence, the device resistance depends on the flow rate and
can be determined for a given filter device by measurement
of water flow rate versus differential pressure.
As a result of Navier-Stokes, fluid flow resistances can be
calculated the same way as in electrical circuits. Resistances





The reciprocal value of resistances connected in parallel
setup add up to the reciprocal value of the total resistance









Furthermore, the resistance of a module can be calculated
in terms of the resistances of the single components that
have a perceptible contribution [24, 31, 44, 45]. Here this
approach will be applied to filter devices. Fig. 2 outlines the
resistances of a device that impact on filtration flow rate. As
the resistance are in series here, they have to be added up.
For a large process, the resistance of the setup depends not
only on the membrane and device design but also on all the
technical equipment, e.g., fittings, tubes or pressure gauges
[32, 33]. Filter fouling contributes to the membrane resis-
tance and leads to an increase in pressure for constant flow
operations or to a decrease in flow rate for constant pres-
sure filtrations as well.
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Figure 2. Components contributing to the resistance of a filtra-






For the experiments described in this paper, various filter
devices and filter discs were used for water flow rate mea-
surements and filtration trials as summarized in Tab. 1. A
particulate test media (0.1 wt % mixture of Caro Kaffee and
Ovomaltine) has been used for the filtration trials with a
viscosity of 1 mPa s and a broad particle size distribution
with a diameter between 0.1 and 10 mm. Measurements are
performed in triplicates. All housings for filter discs use a
steel grid by Haver & Boecker as membrane support.
2.2.1 Design of T-Style MaxiCaps
An example for single-use devices used in process filtration
are T-Style MaxiCaps by Sartorius Stedim Biotech GmbH.
T-Style MaxiCaps filter devices with 0.6 m2, 1.2 m2 and
1.8 m2 embedded membrane area are available, with differ-
ent connector styles and with membranes of different pore
size (Tab. 1). Therefore, they are a good basis for examina-
tion of water flow data. Blueprints of T-Style MaxiCaps
and of the different connector styles are presented in the
Supporting Information. For connector styles always two
letters are given, the first one for the inlet, the second one
for the outlet. In this work, only devices with the same inlet
and outlet are considered: ‘‘O’’ (1/2† single stepped hose
barb), ‘‘S’’ (1 1/2† Tri-Clamp), and ‘‘Y’’ (1† single stepped
hose barb) [46]. All MaxiCaps are made of the same 10†
building blocks containing 0.6 m2 membrane area. For fab-
rication of 20† or 30† MaxiCaps those 10† building blocks
are combined by stacking.
Scaling trials were performed with membrane material
from the Sartopore 2 product family, which contain mem-
branes based on polyether sulfone (PES). A double-layer
membrane sandwich is used with a prefilter/main filter
combination of 0.45/0.2 mm pore size, or a combination of
0.2/0.1 mm pore size.
2.3 Estimation of Flow Properties
The Reynolds number is estimated for fluid flow through
the membrane pores and through the connectors of the
devices according to Eq. (7). For the membrane material a
water flow rate of 21 mL min–1cm–2 (  12600 L h–1m–2)
was measured for Sartopore 2 main filter membrane with
a nominal pore size of 0.2 mm at 1 bar. Pores are assumed to
have a diameter of 0.2 mm and flow rate within a pore is
assumed to be the same as flow rate over the whole filter
disc. Applying this to Eq. (7), a Reynolds number Re << 1 is
obtained. Flow rate through the membrane pores under
common filtration conditions can be assumed to be lami-
nar.
The Reynolds number of a membrane housing depends
only on the inlet and the outlet of T-Style MaxiCaps. This
value can be estimated by the inner diameter. For ‘‘S’’-con-
nectors and ‘‘Y’’-connectors, the inner diameter is 19 mm,
and for ‘‘O’’-connectors 8.8 mm. For devices with 0.6 m2
membrane area, 132 L min–1 water should be able to pass
the device at 1 bar if the complete membrane area is used
and no additional device resistance exists. For the ‘‘S’’-con-
nectors this equals to a Reynolds number of 1.5  106. This
estimation indicates that turbulent flow occurs through the
connectors of the devices. As a consequence, there is a pres-
sure loss that is not related to the membrane.
2.4 Resistance and Effective Filtration Area of
T-Style MaxiCaps by Water Flow Rate
Measurements
Measurement data of water flow rates for T-Style Maxi-
Caps are presented in Fig. 3a for 0.1 mm pore size and in
Fig. 3b for 0.2 mm pore size. For this study T-Style Maxi-
Caps with different membrane areas and devices with dif-
ferent connectors were chosen. The water flow rates that
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Table 1. Overview of performed filtration experiments, membrane areas, connectors and setups used in this paper. For filtration devices
embedded area according to product specification sheet is given [13].
Device Setup Embedded membrane
area [cm2]
Process mode Medium Housing / connectors
25-mm filter discs 1 2.75 constant flow particulate solution stainless-steel filter housing
47-mm filter discs 2 14.1 constant pressure particulate solution stainless-steel filter housing
142-mm filter discs 2 136 constant pressure particulate solution stainless-steel filter housing
Size 4 capsules 2 150 constant pressure particulate solution (3/4†) triclamp
T-Style MaxiCaps 3 10† capsule: 6000 constant pressure water S = 1 1/2† triclamp (inner
diameter of 19 mm)
20† capsule: 12 000 O = 1/2† single stepped hose barb
(inner diameter of 8.8 mm)
30† capsule: 18 000
Y = 1† single stepped hose barb





can be expected according to Darcy’s law are included as
well.
Fig. 3 shows a nonlinear dependency between water flow
rate and pressure of the T-Style MaxiCaps measured.
Water flow rate increases with increasing pressure as
expected, but less than estimated with the Darcy equation.
Connectors have a significant impact on water flow rate at
higher differential pressures if they are undersized. ‘‘O’’-con-
nectors (data in black) are more limiting to flow rate than
‘‘Y’’- or ‘‘S’’-connectors (data in green and red). Further-
more, the data of ‘‘O’’-connectors indicate that inlet and
outlet have the most limiting effect on the water flow rate.
Devices with membranes with a nominal pore size of
0.2 mm (Fig. 3b) show a higher water flow rate than devices
with a membrane with nominal pore size of 0.1 mm (Fig. 3a)
due to the lower membrane resistance. This trend is clearly
obvious for devices with ‘‘S’’- and ‘‘Y’’-connectors. For devi-
ces with ‘‘O’’-connectors hardly any difference can be seen
between different membrane areas or pore sizes.
Doubling or triplicating membrane area (by using 1.2 m2
or 1.8 m2 compared to 0.6 m2) does not have a linear effect
on water flow rate data as can be seen in Fig. 3. Instead the
water flow rate data are clearly lower than expected. These
results can be explained by calculation of the resistance of
each device. Fig. 4 summarizes total device resistances, Rtot
in dependence on water flow rate for the data of T-Style
MaxiCaps presented in Fig. 3. Resistances of T-Style Maxi-
Caps were calculated according to Darcy’s law (Eq. (6)). A
linear relationship between device resistance Rtot and water
flow rate J can be observed.
In a next step, the membrane and the device resistance
are calculated. As discussed in Sect. 2.3, Reynolds numbers
for fluid flow through membrane pores suggest laminar
fluid flow, and Reynolds numbers through connectors of
MaxiCaps indicate turbulent flow. Therefore, for each
device, a linear regression is applied to the Rtot(J) data
(Fig. 4) and the intercept taken as membrane resistance
Rmem. For calculation of the housing resistance according
to Eq. (8) the membrane resistance is subtracted from the
total device resistance, Eq. (11) is obtained. Additionally, the
resistances are examined with regard to each device, so the
membrane area is not included in the Darcy equation here
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Figure 3. Water flow rate data of T-Style MaxiCaps of Sartopore 2 for 0.1 mm pore size (a) and 0.2 mm pore size
(b). Measurement data and expected data according to Darcy’s law for different connector styles and membrane
areas.
Figure 4. Device resistance (Rtot) data of T-Style MaxiCaps
 for 0.1 mm (a) and 0.2 mm (b) pore size, different connec-





The housing resistance Rhousing is calculated by omitting
the membrane resistance Rmem from the device resistance
Rtot as shown in Eq. (11):




Resistances that consider the influence of the respective
cross-section area are marked by a circle. The correlation
between membrane resistance Rmem and specific membrane
resistance Rmem is calculated with the following equation:
Rmem ¼ RmemAmem (12)
Here Amem is the effective membrane area that contrib-
utes to filtration flow rate within a device. The effective
membrane area Amem might be lower than the embedded or
geometrically determined membrane area for constructive
filter design. This is especially the case for larger pleated fil-
ter products with complex flow design. As a consequence, it
can be said for the filter discs that the geometrically mea-
sured membrane area is the effective membrane area; for
the pleated filter devices the effective membrane area is
smaller than the embedded membrane area and should be
measured by H2O flow rate measurements.
Calculated housing resistances Rhousing according to
Eq. (11) are shown in Fig. 5 in dependence on water flow
rate. In Figs. 5a and 5b a line for the ‘‘O’’-connectors
and another for the ‘‘S’’- and ‘‘Y’’-connectors can be
observed, independent of the filtration area and the mem-
brane pore size. For each connector (regardless of the mem-
brane pore size), a linear function is fitted to the data. As
the intercept has been taken out as the membrane resistance
Rmem, they can be described by just one constant ki,
the slope of the line. For ‘‘O’’-connectors, that value is
kO = 1.56 ± 0.04  1013 min m–6, for ‘‘S’’- and ‘‘Y’’-connectors
kS and kY are 0.041 ± 0.001 1013 min m–6. Therefore, the
housing resistance can be described by a function of filtra-
tion flow rate:
Rhousing Jð Þ ¼ kiJ (13)
The intercept in Fig. 4 can be used to calculate the effec-
tive membrane area Amem. If the specific membrane resis-
tance Rmem is precisely known (e.g., due to water flow mea-
surements of a filter disc), that value can be compared to
the measured membrane resistance, Rmem to determine the
effective membrane area Amem via Eq. (12).
The housing resistances Rhousing calculated according to
Eq. (13) and the effective membrane area Amem are the two
main parameters for the scale-up calculations presented in
the following chapters.
2.5 Small-Scale Filtration Experiments for Measure-
ment and Description of Filter Fouling
For scale-up experiments the model solution described in
Sect. 2.2 is used. Filtration experiments are performed with
filter discs of Sartopore 2 (14.1 cm2 effective membrane
area and 136 cm2 effective membrane area, which is equal
to the geometrically determined membrane area given in
Tab. 1). Filter areas have been measured after filtration, as
the test solution dyes the membrane. Filtration is performed
by constant pressures of 0.5 and 1 bar. The measurement
results are presented in Fig. 6.
According to the usual industrial practice, filtration data
are presented in a volume vs. time plot as presented in Fig. 6a.
Filtration flux and the resistances were calculated according
to Eqs. (5) and (6) and plotted versus filtration time and
throughput. The results are presented in Fig. 6b–e. Presen-
tation of data as demonstrated in Fig. 6 allows to visualize
many effects connected with filtration and filter fouling:
– differences of the initial flux caused by a change of pro-
cess conditions or different device resistances (Fig. 6b
and 6d)
– a decrease of filtration time until complete membrane
blocking in case of filtration at higher pressure due to
increasing flow (Fig. 6b)
– it can be shown whether process conditions have an
impact on filter fouling. Resistance vs. throughput curves,
shown in Fig. 6e are identical. They would deviate if
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Figure 5. Resistance data of device housing of T-Style MaxiCaps for 0.1 mm (a) and 0.2 mm (b) pore size, different





filtration process conditions had an impact on filter foul-
ing.
– different resistances of filtration devices are indicated by
different initial values of the resistance versus time or
throughput plots (Figs. 6c and 6e, here device resistances
are equal).
Filter fouling is caused by a separation process. The trans-
port rate of particles is directly proportional to the filtration
flow rate. However, some biopharmaceutical fluid phases,
e.g., protein formulations, can be easily destabilized during
filtration. Colloidal solutions always show a limited thermo-
dynamic stability, shear stress can cause protein aggrega-
tion, and adsorption phenomena can be enhanced by long
residence time of protein near the membrane surface. All
these side reactions lead to additional fouling and can be
influenced by filtration flow rate.
The impact of process conditions on the fouling rate can
be visualized in the resistance vs. throughput plot for con-
stant pressure as well as constant flow driven filtration pro-
cesses.
Upscaling calculations in Section 2.6 and 2.7 are based on
the fact that filter fouling, which occurs in course of filtra-
tion, leads to formation of an additional resistance for the
fouling layer, as can be observed by the increase of mem-
brane resistance in dependence of throughput in course of
filtration (Fig. 6e).
The cause of the increase in membrane resistance or the
mechanism of filter fouling is not important for the upscal-
ing approach. The total resistance of the device can now be
described as a function of flow rate and throughput:
Rtot J; ~V
 
¼ Rhousing Jð Þ þ Rmem ~V
 
(14)
The calculation basis in Sect. 2.6 and 2.7 is summarized
under the assumption that either the same process condi-
tions are used in small scale and large scale, or the process-
dependency of filter fouling is negligible.
2.6 Resistance-Based Scale-up Approach Applied to
Constant Pressure Filtration
In this section, the calculation of the filtration curve for a
large-scale device, based on a test filtration in small scale
and water flow rate measurements in large scale and small
scale is explained. As can be seen in Fig. 6e, resistances of a
large-scale device (variables with index LS) and a small-
scale device (variables with index SS) increase identically in
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Figure 6. Results of filtration experiments with model solution for two different transmembrane pressures and two effec-
tive membrane areas. a) Measured filtration curve, b) calculated filtration flow vs. time, c) calculated area specific resistance





dependence of throughput in course of filtration. The fol-
lowing conclusion is obtained concerning the change of
membrane resistance in course of filtration:
Rmem LS ~V
 
¼ Rmem SS ~V
 
(15)
By transformation with Eq. (12), Eq. (16) is obtained:
Rmem LS ~V
 
ALS ¼ Rmem SS ~V
 
Amem SS (16)
This equation can be used to calculate the membrane
resistance of the large-scale device:
Rmem LS ~V
 








The scale-up factor S is the relationship between the
membrane areas of the small-scale and the large-scale
device, in contrast to recent literature where the scale-up
factor is usually related to batch size. The membrane areas
Amem are the effective membrane areas and can be deter-
mined by water flow rate measurements (Sect. 2.3).







In Eqs. (15)–(18), the specific resistance R, resistance R,
effective membrane area Amem (Eq. (12)) and the scale-up
factor S are used.
For scale-up, first the membrane resistance Rmem SS ~V
 
has to be calculated. For this Eq. (14) is used, with Eq. (13)
for the housing resistance.
Rmem SS ~V
 
¼ Rtot SS ~V ; J
 
 kSSJSS (19)
By use of the scale-up factor S the membrane resistance
Rmem_LS and the respective filtration volume VLS for the









VLS ¼ VSSS (21)
Afterwards the device resistance Rtot LS ~V ; J
 
of the
large-scale device can be calculated using Eq. (6) (Darcy’s
law) and (14).
Rtot LS ~V ; J
 





With regard to Eq. (13) for the housing resistance the fol-
lowing expression can be written:






















The flow rate for the large-scale device can be calculated
according to Eq. (24) after defining the viscosity h, the con-
stant kLS for the device and the process pressure Dptot. As a
last step with the known datasets of flow rate and volume,










With the calculated datasets of time, volume, flow rate
and resistance the large-scale filtration curves can be plot-
ted.
2.7 Resistance-Based Scale-Up Approach Applied to
Constant Flow Rate Filtration
For constant flow rate filtration, scale-up is similar to con-
stant pressure filtration in Sect. 2.6. First, according to
Eq. (19), membrane resistance Rmem SS ~V
 
for the small-
scale filtration has to be calculated. Afterwards, membrane
resistance Rmem LS ~V
 
of the large-scale device has to be
calculated according to Eq. (20). For the target flow rate,
housing resistance is a constant (as JLS is a constant) and
just has to be added up according to Eq. (22) for calculation
of the device resistance. Filtrate volume can be calculated by
Eq. (21), the timescale is calculated by Eq. (25).
In constant flow filtration the filtration flow rate is in
theory just a constant. So, the J ~V
 
plot shows a straight
line. However, in reality filtration flow rate is usually ad-
justed by a pump that generates pulsating pressure. In this
case the fluctuations can be observed in the measured filtra-
tion flow rate. So, if the flow rate profile that is generated by
the pump is known (because of old process data or because
in the small-scale trial a comparable pump is used), this
flow profile can be used for the calculation of the large-scale
process data as well. This way the fluctuation of the pres-
sure for the large-scale device can be predicted. This
approach is used for the example given in Sect. 3.2.
The pressure difference across the large-scale device is
received by transforming Eq. (23) to Eq. (26):
Dp J; ~V
 
¼ kLSJ2hþ Rmem LS ~V
 
(26)
With the generated datasets of time, volume, flow rate,
resistance and differential pressure process now the large-
scale filtration curves can be plotted.






In Sect. 2.6 and 2.7 it was shown that the filtration curve of
a filter device can be calculated on the basis of the filtration
curve of a scaling device and its resistance vs. throughput
plot, Rmem SS ~V
 
. Now two scaling examples are presented.
3.1 Upscaling Example – Constant Pressure
Filtration
Small-scale filtration was performed at constant pressure
filtration at 0.5 bar, using a 47-mm Sartopore 2 membrane
filter disc with 0.45 mm/0.2mm nominal pore size combina-
tion. Large-scale filtration case is filtration through a size 4
capsule of Sartopore 2 at 1 bar.
First, water flow rate has been measured at 0.3, 0.5 and
1 bar for both devices to determine the constant ki and the
initial membrane resistance Rmem ~V ¼ 0
 
as described in
Sect. 2.4. The measured resistance and water flow rate data
of both devices are shown in Fig. 7 and Tab. 2.
The scale-up factor was calculated according to
Eq. (18). With Eq. (18), the effective membrane area for
the size 4 capsule of Sartopore 2 can be calculated with
ALS = 116 cm
2. This value, which is used for the calcula-
tions, is lower than the embedded filter area of 150 cm2
[13]. The difference between embedded and effective filter
area can be explained by the different fluid dynamics of flat
filter devices and pleated filter devices as already discussed
in Sect. 2.4.
The device resistance is defined by the slope ki and the
membrane resistance Rmem ~V ¼ 0
 
. For the calculation of
the membrane resistance Rmem ~V
 
of the large-scale device
Eq. (17) is used. Subsequently, Eq. (24) and (25) are used for
calculation of filtration data for size 4 capsule. The resulting
plots comparing the experimental and predicted values are
depicted in Fig. 8, showing excellent agreement between
both datasets.
3.2 Downscaling Example – Downscaling of a
Constant Pressure Filtration Experiment to
Constant Flow Filtration
With the approach presented in Sect. 2.7, constant flow fil-
tration curves can be calculated based on a constant pres-
sure filtration. In this section the procedure is demonstrated
for a downscaling case. Large-scale filtration case is a con-
stant pressure filtration at 0.5 bar using a 47-mm Sarto-
pore 2 membrane filter disc. Small-scale filtration case is
filtration through a 25-mm Sartopore 2 membrane filter
disc at constant flow of 14 mL min–1cm–2. Again, the partic-
ulate test solution described in Sect. 2.2 was filtered and the
calculated data were finally verified by experiment.
As the membrane areas and the filtration flow rate are
quite small, housing resistance in form of the constant ki is
assumed to be zero, as the standard deviations exceed the
actual values for ki. The effective membrane area is mea-
sured by the area of the filter disc that was colored brown
by the test solution.
The results are shown in Fig. 9. First the volume is calcu-
lated by Eq. (21) (Fig. 9a). The timescale is received by
Eq. (25). Eq. (26) is used for calculation of the differential
pressure (Fig. 9d). By using Eq. (5), filtration flux data
(Fig. 9b and 9e) is predicted.
No differences can be seen in plot (a) between predicted
and experimental data, because this is the assumed dataset
for the calculations of flux, differential pressure and resis-
tance. Plot (b) and (e) show for the calculated flow rate data
no straight line, because the values shown were calculated
by derivation of the volume data obtained by constant pres-
sure filtration. The important data for a process design is
the pressure vs. time plot (d). Here it can be seen that the
predicted data is at the beginning a little low and near the
end too high compared to experiment. Possible explana-
tions are due to a missing vent in the small-scale filter hous-
ing at the beginning of the experiment probably air at the
pressure sensor increases the measurement values. The
deviation at the end of the experiment could occur because
of batch variations of the filter discs.
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water flow rate J [l/min]
 size 4 capsule
 47 mm filter disc
Figure 7. Results for water flow measurements of 47-mm filter
disc and size 4 capsule of Sartopore 2.
Table 2. Results of water flow rate measurements for 47-mm








47 mm 390 ± 131 1.67 ± 0.03 14.1
Size 4
capsule







In this work, a flow rate and resistance-based approach is
presented for upscaling of filtration processes. For this con-
cept, first the respective process conditions have to be
defined (constant flow, constant pressure, batch size and
maximum filtration time). Moreover, appropriate small-
scale tests have to be performed.
The upscaling concept comprises:
– the measurement and analysis of filtration curves of a
lab-scale filter device,
– the estimation of the required filter area and the selection
of a suitable filtration device for filtration of a target fil-
tration volume,
– the measurement of resistance and filter area of scaling
and targeted filter device by pressure dependent H2O-
flow measurements,
– the modeling of the resistance vs. throughput plot (Rtot
vs. ~V) of the targeted device under target filtration condi-
tions; and finally flow rate and the filtered volume vs.
time plots can be calculated.
Basic requirements for the calculations are the knowledge
of the precise effective membrane areas and the device resis-
tances, both determined by water flow measurements. A
resistance-in-series model is used to describe the device
resistances.
The validity of this approach was demonstrated by
filtration data of a particulate test solution through Sarto-
pore 2 membrane filters at different scale. An excellent
comparability of predicted and experimental data could be
achieved.
The necessary calculation approach is summarized. The
modeling can be used for constant flow and constant pres-
sure filtration and does not require the knowledge of the
blocking mechanism. The approach can be used for upscal-
ing and downscaling of a filtration process, which mini-
mizes experimental efforts for process development.
Supporting Information
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Figure 8. Filtration data of 14.1-cm2 filter disc at 0.5 bar (green), size 4 capsule at 1 bar (red) and predicted data based on







2] active membrane area
Abatch [m
2] area needed for filtration of a
batch
Adevice [m
2] membrane area within a device
ASS [m
2] membrane area used for small-
scale experiments
ALS [m
2] membrane area used for large-
scale experiments
Atest [m
2] filtration area used for test
filtration
J [mL min–1] flow rate
J [mL min–1cm–2] filtration flux
ki [10
10 min m–6] constant, specific for each device
and describes the relationship of
device resistance and flow rate
Dp [bar] pressure difference across
membrane
Dptot [bar] pressure difference across device
Re [–] Reynolds number
Rdev [10
10 m–1] resistance of a device, normed
by membrane area
Rhousing [10
10 m–3] housing resistance
Rin [10
10 m–3] resistance inlet
RLS [10
10 m–3] membrane resistance large-scale
device
RLS [10
10 m–1] membrane resistance large-scale
device
Rmem [10
10 m–3] membrane resistance
Rmem [10
10 m–1] specific membrane resistance
RSS [10
10 m–3] membrane resistance of small-
scale device
RSS [10
10 m–1] membrane resistance small-scale
device
Rout [10
10 m–3] resistance outlet
Rtot [10
10 m–3] measured resistance of a whole
device
Rtot [10
10 m–1] measured resistance of a whole
device
S [–] scale-up factor
SF [–] safety factor for scale-up process
design
t [s] time (progress of filtration
experiment)
Dt [s] time difference between two
adjacent data points
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Figure 9. Prediction of a 25-mm constant flow filtration with 14 mL min–1cm–2 out of a constant pressure filtration with





DV [L] difference in filtrate volume
between two adjacent data
points
V [L] filtrate volume
~V [L m–2] filtrate volume per effective
membrane area
VBatch [L] batch size of upscaled process
VLS [L] filtrate volume as calculated out
of small-scale experiment
Vfinal [L] maximum filterable amount
determined by a test filtration
VSS [L] filtrate volume as measured in
small-scale experiment
h [mPa s] viscosity
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